NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM1101778 Query DataSets for GSM1101778
Status Public on Mar 19, 2013
Title E. faecalis OG1RF control replicate 4
Sample type RNA
 
Channel 1
Source name Control OD600 = 0.3 RNA
Organism Enterococcus faecalis OG1RF
Characteristics growth phase: OD600 = 0.3
treatment: control
time: control
Growth protocol Cells were grown in FMC medium supplemented with 10 mM glucose to OD600 of 0.3 at 37°C.
Extracted molecule total RNA
Extraction protocol RNA was isolated from homogenized E. faecalis cells grown in BHI medium to OD600 of 0.3 with or without exposure to antibiotics by repeated hot acid-phenol: chloroform extractions, and the nucleic acid was precipitated with 1 volume ice-cold isopropanol and one-tenth volume 3M sodium acetate (pH 5) at –20°C overnight. RNA pellets were resuspended in 80 mL nuclease-free H2O, and treated with DNase I (Ambion) at 37°C for 30 minutes. RNA concentrations were determined using a Nanodrop ND-1000 Spectrophotometer (Thermo Fisher Scientific, Waltham, MA), and 1 mL samples were run on an agarose gel to verify RNA integrity. The RNA was purified again using the RNeasy mini kit (Qiagen), including a second on-column DNase treatment that was performed as recommended by the supplier. Final RNA concentrations were determined in triplicate.
Label Cy3
Label protocol Once RNA was purified as described above, cDNA was generated from 2ug RNA per sample as described by the protocol available from the Pathogen Functional Genomics Research Center (PFGRC) using Invitrogen Superscript III Reverse Transcriptase (Invitrogen, Gaithersburg, MD) to increase cDNA yields. Purified cDNAs were coupled to Cy3 (experimental samples) or Cy5 (reference cDNA).
 
Channel 2
Source name wild-type mid-log RNA
Organism Enterococcus faecalis OG1RF
Characteristics treatment: reference
Growth protocol Cells were grown in Brain-Heart medium to OD600 of 0.5 at 37°C.
Extracted molecule total RNA
Extraction protocol RNA was isolated from homogenized E. faecalis cells grown in BHI medium to OD600 of 0.3 with or without exposure to antibiotics by repeated hot acid-phenol: chloroform extractions, and the nucleic acid was precipitated with 1 volume ice-cold isopropanol and one-tenth volume 3M sodium acetate (pH 5) at –20°C overnight. RNA pellets were resuspended in 80 mL nuclease-free H2O, and treated with DNase I (Ambion) at 37°C for 30 minutes. RNA concentrations were determined using a Nanodrop ND-1000 Spectrophotometer (Thermo Fisher Scientific, Waltham, MA), and 1 mL samples were run on an agarose gel to verify RNA integrity. The RNA was purified again using the RNeasy mini kit (Qiagen), including a second on-column DNase treatment that was performed as recommended by the supplier. Final RNA concentrations were determined in triplicate.
Label Cy5
Label protocol Once RNA was purified as described above, cDNA was generated from 2ug RNA per sample as described by the protocol available from the Pathogen Functional Genomics Research Center (PFGRC) using Invitrogen Superscript III Reverse Transcriptase (Invitrogen, Gaithersburg, MD) to increase cDNA yields. Purified cDNAs were coupled to Cy3 (experimental samples) or Cy5 (reference cDNA).
 
 
Hybridization protocol The slides were hybridized to a mixture containing equal amounts of test and reference cDNA for 16 h at 42°C in a MAUI hybridization chamber (BioMicro Systems). Hybridized slides were washed and scanned using a GenePix scanner (Axon Instruments).
Scan protocol Hybridized slides were washed and scanned using a GenePix scanner (Axon Instruments, Inc., Union City, CA).
Data processing Data were analyzed using software available at the J. Craig Venter Institute PFGRC website. Single-channel images of the slides were loaded into Spotfinder and overlaid. A spot grid was created according to PFGRC specifications and manually adjusted to fit all spots. The Microarray Data Analysis System (MIDAS) software was used to normalize the spot intensity data using LOWESS and iterative log mean centering with default setting. MIDAS also utilized In-Slide Replicate Analysis to average the intensities of the spots that were replicated on the microarray slide. Spots that were missing or labeled as “bad” during the upstream processes in 50% of the slides were cut off in the output files, which also did not include control spots printed on the slides. Statistical analysis was carried out with BRB array tools (http://linus.nci.nih.gov/BRB-ArrayTools.html) with a cutoff P value of 0.001.
 
Submission date Mar 19, 2013
Last update date Mar 19, 2013
Contact name Jessica K Kajfasz
E-mail(s) jkajfasz@dental.ufl.edu
Organization name University of Florida
Department Oral Biology
Lab Lemos-Abranches
Street address 1395 Center Drive
City Gainesville
State/province FL
ZIP/Postal code 32610
Country USA
 
Platform ID GPL15039
Series (2)
GSE45300 Enterococcus faecalis OG1RF control vs. treatment with vancomycin
GSE45306 Enterococcus faecalis OG1RF control vs. treatment with ampicillin, bacitracin, cephalothin, or vancomycin

Data table header descriptions
ID_REF
VALUE normalized log2 ratio (Cy3/Cy5) representing test/reference

Data table
ID_REF VALUE
HMPREF0345_0001 -0.763474418
HMPREF0345_0002 -0.180905663
HMPREF0345_0003 1.306376641
HMPREF0345_0004 0.145215317
HMPREF0345_0005 0.677132345
HMPREF0345_0006 0.691413442
HMPREF0345_0007 0.439451398
HMPREF0345_0008 0.773630471
HMPREF0345_0009 0.188766598
HMPREF0345_0010 0.050098612
HMPREF0345_0011 0.362711057
HMPREF0345_0012 0.018555819
HMPREF0345_0013 -0.497261357
HMPREF0345_0014 -0.692436889
HMPREF0345_0015 0.187808185
HMPREF0345_0016 0.551871714
HMPREF0345_0017 -0.399293436
HMPREF0345_0018 0.130188219
HMPREF0345_0019 0.119126328
HMPREF0345_0020 0.400138623

Total number of rows: 5274

Table truncated, full table size 145 Kbytes.




Supplementary file Size Download File type/resource
GSM1101778_Control_4.mev.gz 563.0 Kb (ftp)(http) MEV
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap